RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Cheap Valuationporksniffer wrote: gudisgood wrote: porksniffer wrote: curiousj wrote: I appreciate the devil's advocate role you play... would you disagree that this is already priced in by investors?
Also, what are you looking for to buy GUD? if you're not interested in buying, are you short GUD and what would make you positive?
This stock was driven to over $11 by investors relying on PAST performance of a LUCKY CEO. He even admitted he got lucky.
Now you and and everyone else on this board is trapped like a rat in some stock that sells old drugs tossed away by their creators. What is priced in is what is known today. The markets they sell to are unstable.
I, like you got trapped. But I sold out over a year ago for a bit more than current price, booked a loss and promptly doubled my money elsewhere. Liberating and profitable. You would be wise to do the same. Unlike Chianchin, I am not as polite; MugMod should be investigated for the pumping and frauds he's committed. I hope you are not being influenced by his pumping. He has been wrong for 10 years. While Chianchin and other bears have got it spot on. This is a loser stock, the CEO was already a billionaire and retired. His wealth does not depend on this stock. Your does. Let that sink in.
Congratulations on promptly doubling your money!
I do appreciate opposing views. What I would appreciate even more is reasoning behind the negative opinions. Just pointing out the share price is essentially meaningless. How much money do you think Knight will generate, say, three, four, or five years from now? What's your estimation of a fair value for this company?
"Drugs tossed away by their creators"... yes, one of the company's strategies is to look for drugs that fit the portfolio and that current owners don't pay much attention to. "Tossed away" is not exactly what happened with Exelon.
"What is priced in is what is known today"... okay, so why buy any stock then? How do you find those stocks that promptly double your money if everything is priced in? Or is it just in the case GUD?
"The markets they sell to are unstable"... certainly there's some merit to this statement. However, LatAm and everything that comes with it is a part of the reason why GUD is there. They want to be the partner of choice in a challenging environment.
I would love for the share price to have performed better over the past couple of years. On the other hand, this game is not supposed to be easy. The plus side is every shareholder gets to own a higher share of the company via buybacks at these prices.
Not going to have this discussion with you because we had it 3,4,5 years back. Feel free to look back to years of my posts here. I was negative since then.
As far as I'm concerned nothing has changed. This stock is going lower and you and MANY other bought it because of the past record of the lucky CEO and you now need to re-examine why you still own it when it has been painfully obvious this will NOT be the next Palladin Lab because Palladin Lab was a fluke. Don't be fooled by buybacks. Management has been buying back in the mid $7's years ago. Every single share purchased is underwater. Millions have been lost. All it does is make the privatization cheaper for the JRG or some shark posing as a white night like Armoyan using YOUR money. When the stock is in the $3's you will be offered a token 15-25% premium....if you're lucky. That is the best you can hope for here.
I don't remember having this discussion with you. Again, your post highlights share performance but makes no mention of why this business is doomed to fail. Why, for instance, is the cash flow more likely to decrease than increase in the future?
Why is a company with $145M in cash and marketable securities, $167M in financial assets, $40M+ in operational cash flow (generated by a growing portfolio of drugs) and a $33M debt position worth $3 a share... so about $340M?